title: Binding of sesquiterpene lactone inhibitors to the Ca(2+)-ATPase.
abstract: The mechanism of inhibition of the Ca(2+)-ATPase from sarcoplasmic reticulum by the sesquiterpene lactones thapsigargin, trilobolide and thapsivillosin A (TvA) has been determined. A decrease in the affinity of the ATPase for Ca2+ is observed in the presence of the inhibitors (I), consistent with a shift in the E1/E2 equilibrium for the ATPase towards E2 forms. Amounts of inhibitor beyond a 1:1 molar ratio with ATPase produce no further decrease in affinity for Ca2+, inconsistent with the formation of a dead-end complex. Measurements of the rate of quenching of the tryptophan fluorescence of the ATPase by TvA are consistent with an association step to give E2I followed by an isomerization to a modified state E2AI. The kinetics of the reversal of the effects of TvA by Ca2+ at sub-stoichiometric amounts of TvA are bi-exponential, with a fast component whose rate is independent of TvA concentration and equal to the rate observed in the absence of TvA, and a slow component whose rate decreases with increasing TvA concentration. These observations are also consistent with the formation of a modified state E2AI following the initial binding of I to E2. The equilibrium constant E2AI/E2I increases in the order TvA < trilobolide < thapsigargin. The results suggest that the effects of the inhibitors on the overall ratio of E2 to E1 forms of the ATPase follow largely from the formation of E2AI from E2I, and that binding constants are very similar for E1Ca2, E1 and E2.
authors.affiliation: Department of Biochemistry, University of Southampton, Hants, U.K.
authors.forename: M
authors.initials: M
authors.lastname: Wictome
authors.forename: Y M
authors.initials: YM
authors.lastname: Khan
authors.forename: J M
authors.initials: JM
authors.lastname: East
authors.forename: A G
authors.initials: AG
authors.lastname: Lee
mesh_terms: D000818:Animals; D001665:Binding Sites; D002087:Butyrates / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D000252:Calcium-Transporting ATPases / Q000737:chemistry* / Q000302:isolation & purification / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000378:metabolism*; D005663:Furans / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D007783:Lactones / Q000494:pharmacology; D008433:Mathematics; D008962:Models, Theoretical; D018482:Muscle, Skeletal / Q000201:enzymology; D012519:Sarcoplasmic Reticulum / Q000201:enzymology; D012717:Sesquiterpenes / Q000494:pharmacology*; D013729:Terpenes / Q000494:pharmacology; D019284:Thapsigargin
chemical_list: D002087:Butyrates; D004791:Enzyme Inhibitors; D005663:Furans; D007783:Lactones; D012717:Sesquiterpenes; D013729:Terpenes; C086352:trilobolide; D019284:Thapsigargin; C095812:thapsivillosin A; D000252:Calcium-Transporting ATPases; D002118:Calcium